Palantir Technologies Inc
For the period ended Sep 30, 2024. Filed Nov 5, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 5, 2024
PLTR$168.82-0.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
| Nine Months Ended September 30, | ||
|---|---|---|
| 2024 | 2023 | |
| Operating activities | ||
| Net income | $390,982 | $120,462 |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Depreciation and amortization | 24,581 | 25,382 |
| Stock-based compensation | 409,840 | 343,295 |
| Noncash operating lease expense | 32,041 | 34,810 |
| Unrealized and realized (gain) loss from marketable securities, net | 26,021 | 11,810 |
| Noncash consideration | (34,789) | (34,852) |
| Other operating activities | 19,115 | (13,328) |
| Changes in operating assets and liabilities: | ||
| Accounts receivable, net | (311,699) | (159,752) |
| Prepaid expenses and other current assets | (19,547) | (75) |
| Other assets | 4,056 | 1,941 |
| Accounts payable | 7,710 | (32,387) |
| Accrued liabilities | 42,149 | 2,552 |
| Deferred revenue, current and noncurrent | (27,117) | 64,464 |
| Customer deposits, current and noncurrent | 159,457 | 84,272 |
| Operating lease liabilities, current and noncurrent | (35,205) | (37,767) |
| Other noncurrent liabilities | 5,943 | 184 |
| Net cash provided by operating activities | 693,538 | 411,011 |
| Investing activities | ||
| Purchases of property and equipment | (9,528) | (10,254) |
| Purchases of marketable securities | (3,418,699) | (4,791,670) |
| Proceeds from sales and redemption of marketable securities | 2,451,378 | 2,608,898 |
| Proceeds from sales of alternative investments | — | 51,072 |
| Other investing activities | (4,000) | — |
| Net cash used in investing activities | (980,849) | (2,141,954) |
| Financing activities | ||
| Proceeds from the exercise of common stock options | 270,207 | 166,829 |
| Repurchases of common stock | (45,598) | — |
| Other financing activities | 91 | 778 |
| Net cash provided by financing activities | 224,700 | 167,607 |
| Effect of foreign exchange on cash, cash equivalents, and restricted cash | 960 | (2,113) |
| Net decrease in cash, cash equivalents, and restricted cash | (61,651) | (1,565,449) |
| Cash, cash equivalents, and restricted cash - beginning of period | 850,107 | 2,627,335 |
| Cash, cash equivalents, and restricted cash - end of period | $788,456 | $1,061,886 |
Theaccompanying notes are an integral part of these condensed consolidated financial statements.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.